Page last updated: 2024-10-27

fenofibrate and Colorectal Neoplasms

fenofibrate has been researched along with Colorectal Neoplasms in 2 studies

Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE

Colorectal Neoplasms: Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Strowitzki, MJ1
Radhakrishnan, P1
Pavicevic, S1
Scheer, J1
Kimmer, G1
Ritter, AS1
Tuffs, C1
Volz, C1
Vondran, F1
Harnoss, JM1
Klose, J1
Schmidt, T1
Schneider, M1
Lachal, S1
Ford, J1
Shulkes, A1
Baldwin, GS1

Other Studies

2 other studies available for fenofibrate and Colorectal Neoplasms

ArticleYear
High hepatic expression of PDK4 improves survival upon multimodal treatment of colorectal liver metastases.
    British journal of cancer, 2019, Volume: 120, Issue:7

    Topics: Aged; Animals; Antineoplastic Agents; Colorectal Neoplasms; Combined Modality Therapy; Down-Regulati

2019
PPARalpha agonists stimulate progastrin production in human colorectal carcinoma cells.
    Regulatory peptides, 2004, Aug-15, Volume: 120, Issue:1-3

    Topics: Bezafibrate; Cell Proliferation; Clofibrate; Clofibric Acid; Colorectal Neoplasms; Fenofibrate; Fibr

2004